Hemangioblastoma

When you're facing a hemangioblastoma diagnosis, count on us for care that inspires confidence. Hemangioblastoma tumors are benign, slow-growing and well-defined, meaning they don’t spread beyond the original tumor formation. They often grow in the lower portion of the brain — the cerebellum — or the brain stem, where they emerge from the lining of the blood vessels. Common symptoms include headaches, nausea and vomiting, gait disturbances and poor limb coordination. Hemangioblastoma is more prevalent in men, people between ages 30 and 40 and those with von Hippel-Lindau disease.

Within the AdventHealth Neuroscience Institute network, we specialize in minimally invasive treatments that use laser technology, 3D brain mapping and GPS-like neuronavigation to remove hemangioblastoma tumors or reduce their size. These advanced techniques often minimize damage to surrounding tissue and result in less scarring and pain. Patients generally recover more quickly. Minimally invasive surgery may be an effective option for some patients with brain tumors that are unresponsive to traditional therapies or surgery.